Improving acceptance of COVID-19 rapid testing in Latinx communities
Enhancing SARS-Co-V-2 Rapid Testing Acceptance in Latinx Communities
This study is working to make COVID-19 rapid testing more accepted and accessible for Latinx communities by using a friendly approach that respects their culture and addresses concerns like mistrust, while providing helpful resources in both English and Spanish.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oregon NIH-funded |
| Lab location | 1 site (Eugene, United States) |
| Project ID | NIH-10845414 on NIH RePORTER |
What this research studies
This project focuses on enhancing the acceptance of SARS-CoV-2 rapid testing among Latinx communities by implementing a culturally tailored intervention. It utilizes a brief behavioral self-affirming implementation intention (SAII) to promote health equity and reduce health disparities. The intervention aims to address barriers such as discrimination and mistrust, while also providing resources in both English and Spanish to ensure accessibility. By evaluating the effectiveness of this approach, the research seeks to improve health outcomes related to COVID-19 testing and vaccination.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals from Latinx communities who may face barriers to COVID-19 testing due to discrimination or mistrust.
Not a fit: Patients who are not part of the Latinx community or those who do not face barriers related to testing acceptance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased acceptance of COVID-19 rapid testing and improved health outcomes in Latinx communities.
How similar studies have performed: Previous phases of this project have shown success in implementing similar health promotion interventions in vulnerable populations.
Where this research is happening
Eugene, United States
- University of Oregon — Eugene, United States (Active)
Researchers
- Principal investigator: Degarmo, David S. — University of Oregon
- Study coordinator: Degarmo, David S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.